SeQuent Scientific Surges 10% Amid Foreign Fund Buying

Shares in SeQuent Scientific Ltd surged nearly 10 per cent, adding to their 10 per cent surge in the previous session, after several foreign investors bought the company's stock via bulk deals on Tuesday.

Morgan Stanley Asia, Merrill Lynch Capital Markets Espana and Route One Fund bought about 0.4 million shares each at Rs 250 per share, BSE data shows.

SeQuent is engaged in the development and manufacture of pharmaceuticals and speciality chemicals.

Copyright: Thomson Reuters 2014